The corporate venture capital arm of a global beauty and health company is looking to invest in in early and later stage opportunities which are strategically relevant to and complement the firm’s current product lines. The firm’s investment size is USD 2-5 million per company per round with reserved follow-on investments. The firm can invest globally and is actively seeking new investment opportunities.
In the Life Sciences, the firm seeks to invest in emerging companies that develops novel cosmetic therapeutics and related medical devices. The firm’s investment focuses include dermatology therapeutics targeting, acne, stretch marks, rosacea, psoriasis, anti-fungal, as well as post-surgical treatment such as wound healing and scars. Other areas of interest include technology enhancing topical ingredient delivery, novel formulation technologies, emerging biotechnologies such as stem cells, gene profiling for cosmetic indications are also of interest.
On a case by case basis the firm can act as lead investor or participate in a syndicate.
If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com
Leave a Reply